Browse by Person

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | No Grouping
Jump to: Article
Number of items: 2.


Coleman, RE, Collinson, M, Gregory, W et al. (20 more authors) (2018) Benefits and risks of adjuvant treatment with zoledronic acid in stage II/III breast cancer. 10 years follow-up of the AZURE randomized clinical trial (BIG 01/04). Journal of Bone Oncology, 13. pp. 123-135. ISSN 2212-1374

Coleman, R, Hall, A, Albanell, J et al. (10 more authors) (2017) Influence of MAF gene amplification on treatment effects in the AZURE (BIG 01/04) prospective clinical trial of adjuvant zoledronic acid in early breast cancer. The Lancet Oncology. ISSN 1470-2045 (In Press)

This list was generated on Sun Aug 18 17:45:48 2019 BST.